On July 10, 2023, Deborah L. Birx, a member of the Board of Directors of Innoviva, Inc. (the Board") and chair of the Audit Committee, resigned from the Board, including the committees of the Board of which she is a member, effective as of July 10, 2023, AND ACCEPTED the position of Chief Executive Officer of Armata Pharmaceuticals, Inc., a company in which Innoviva holds a majority ownership interest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.26 USD | +1.80% | +2.07% | -4.86% |
1st Jan change | Capi. | |
---|---|---|
-4.86% | 965M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- INVA Stock
- News Innoviva, Inc.
- Innoviva, Inc. Announces Resignation of Deborah L. Birx as Member of the Board of Directors and Chair of the Audit Committee